TrialCardiovascular diabetology2024

The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator.

Roopameera Thirumathyam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.